Research graph
References from Association of 18F-FDG PET/CT Radiomics with Tumor Molecular Features in Breast Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Histological type and typing of breast carcinomas and the WHO classification changes over time
10.32074/1591-951x-1-20 · 2020 · External reference
Biological subtypes of breast cancer: prognostic and therapeutic implica-tions
10.5306/wjco.v5.i3.412 · 2014 · External reference
10.1016/j.molonc.2010.04.004
10.1016/j.molonc.2010.04.004 · External reference
Tumor heterogeneity: causes and consequences
10.1016/j.bbcan.2009.11.002 · 2010 · External reference
10.1016/s0140-6736(11)60993-8
10.1016/s0140-6736(11)60993-8 · External reference
10.1371/journal.pone.0021030
10.1371/journal.pone.0021030 · External reference
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
10.1093/annonc/mdz173 · 2019 · External reference
10.31590/ejosat.780052
10.31590/ejosat.780052 · External reference
Radiomics: extracting more information from medical images using advanced feature analysis
10.1016/j.ejca.2011.11.036 · 2012 · External reference
Overview of radiomics in breast cancer diagnosis and prognostication
10.1016/j.breast.2019.10.018 · 2020 · External reference
Quantitative FDG PET Assessment for oncology therapy
10.3390/cancers13040869 · 2021 · External reference
Estrogen and proges-terone receptor testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update
10.5858/arpa.2019-0904-sa · 2020 · External reference
Human epidermal growth factor receptor 2 testing in breast cancer: American So-ciety of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Fo-cused Update
10.5858/arpa.2018-0902-sa · 2018 · External reference
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
10.1093/annonc/mdt303 · 2013 · External reference
LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity
10.1158/0008-5472.can-18-0125 · 2018 · External reference
the image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping
10.1148/radiol.2020191145 · 2020 · External reference
PET radi-omics signatures and artificial intelligence for decoding immunotherapy response in advanced cutaneous squamous cell carcinoma: a retrospective single-center study
10.3390/app15126453 · 2025 · External reference
Joint EANM/SNMMI guideline on radiomics in nuclear medicine : Jointly supported by the EANM Physics Committee and the SNMMI Physics, Instrumentation and Data Sciences Council
10.1007/s00259-022-06001-6 · 2023 · External reference
10.1371/journal.pone.0145063
10.1371/journal.pone.0145063 · External reference
Radiomics in breast cancer classification and prediction
10.1016/j.semcancer.2020.04.002 · 2021 · External reference
Unresolved reference
External reference
Metabolic radiomics for pretreatment 18F-FDG PET/CT to characterize locally advanced breast cancer: histopathologic characteristics, response to neo-adjuvant chemotherapy, and prognosis
10.1038/s41598-017-01524-7 · 2017 · External reference
[18F]FDG PET/CT features for the molecular characterization of primary breast tumors
10.1007/s00259-017-3770-9 · 2017 · External reference
Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer
10.1007/s00259-017-3830-1 · 2018 · External reference
10.4274/mirt.galenos.2022.59140
10.4274/mirt.galenos.2022.59140 · External reference
Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer
10.1097/mnm.0000000000001019 · 2019 · External reference
10.1371/journal.pone.0094017
10.1371/journal.pone.0094017 · External reference
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and tex-tural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients
10.1007/s00259-017-3641-4 · 2017 · External reference
Prediction of HER2 expression in breast can-cer by combining PET/CT radiomic analysis and machine learning
10.1007/s12149-021-01688-3 · 2022 · External reference
Glucose metabolism in cancer: the warburg effect and beyond
10.1007/978-3-030-65768-0_1 · 2021 · External reference
The biological roles and clinical applications of the PI3K/AKT pathway in targeted therapy resistance in HER2-Positive breast cancer: a comprehensive review
10.3390/ijms252413376 · 2024 · External reference
Targeting mTOR and glycolysis in HER2-positive breast cancer
10.3390/cancers13122922 · 2021 · External reference
Association between 18F-FDG uptake and molecular subtype of breast cancer
10.1007/s00259-015-3070-1 · 2015 · External reference
